CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...